Here we critically review the recent literature that describes the rationale for curative therapies and the resulting compounds that are being tested in clinical trials for hepatitis B
[] Weight loss in obese individuals is associated with decreased risks of type 2 diabetes (T2D), fatty liver disease, hypertension, cardiovascular disease, sleep apnoea, and osteoarthritis
The reasoning that follows extrapolates from dog, monkey and rat, and species extrapolation of clearance is an inference, not a demonstration
Cogliati, S., Cabrera-Alarcn, J
p53 as a dichotomous regulator of liver disease: the dose makes the medicine
With studies examining acute and chronic toxicity, organ histopathology, haematological parameters, and systemic biomarkers following BPC-157 and TB-500 administration at research-relevant doses